Cargando…

Live cell detection of chromosome 2 deletion and Sfpi1/PU1 loss in radiation-induced mouse acute myeloid leukaemia()

The CBA/H mouse model of radiation-induced acute myeloid leukaemia (rAML) has been studied for decades to bring to light the molecular mechanisms associated with multistage carcinogenesis. A specific interstitial deletion of chromosome 2 found in a high proportion of rAML is recognised as the initia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olme, C.-H., Finnon, R., Brown, N., Kabacik, S., Bouffler, S.D., Badie, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pergamon Press 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775122/ https://www.ncbi.nlm.nih.gov/pubmed/23806234 http://dx.doi.org/10.1016/j.leukres.2013.05.019

Ejemplares similares

Frequency of acute myeloid leukaemia-associated mouse chromosome 2 deletions in X-ray exposed immature haematopoietic progenitors and stem cells()
por: Olme, C.-H., et al.
Publicado: (2013)

Flt3-ITD mutations in a mouse model of radiation-induced acute myeloid leukaemia
por: Finnon, R, et al.
Publicado: (2012)

PU.1 downregulation in murine radiation-induced acute myeloid leukaemia (AML): from molecular mechanism to human AML
por: Verbiest, Tom, et al.
Publicado: (2015)

Transcriptomic and proteomic analysis of mouse radiation-induced acute myeloid leukaemia (AML)
por: Badie, Christophe, et al.
Publicado: (2016)

Kras mutations and PU.1 promoter methylation are new pathways in murine radiation-induced AML
por: O’Brien, Gráinne, et al.
Publicado: (2020)

Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment
por: Badie, C, et al.
Publicado: (2008)

NOD Scid Gamma Mice Are Permissive to Allogeneic HSC Transplantation without Prior Conditioning
por: Verbiest, Tom, et al.
Publicado: (2016)

Tracking preleukemic cells in vivo to reveal the sequence of molecular events in radiation leukemogenesis
por: Verbiest, Tom, et al.
Publicado: (2018)

Modeling low-dose radiation-induced acute myeloid leukemia in male CBA/H mice
por: Stouten, Sjors, et al.
Publicado: (2020)

Seeking genetic signature of radiosensitivity - a novel method for data analysis in case of small sample sizes
por: Zyla, Joanna, et al.
Publicado: (2014)

Genome-scale definition of the transcriptional programme associated with compromised PU.1 activity in acute myeloid leukaemia
por: Sive, J I, et al.
Publicado: (2016)

PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development
por: Zhao, Xinhui, et al.
Publicado: (2022)

Vav1 is necessary for PU.1 mediated upmodulation of miR‐29b in acute myeloid leukaemia‐derived cells
por: Vezzali, Federica, et al.
Publicado: (2018)

Mutations of the transcription factor PU.1 are not associated with acute lymphoblastic leukaemia
por: Mueller, B U, et al.
Publicado: (2006)

Mutations of the transcription factor PU.1 are not associated with acute lymphoblastic leukaemia
por: Mueller, B U, et al.
Publicado: (2006)

Automated Synthesis of Fluorine-18 Labeled CXCR4 Ligand via the Conjugation with Nicotinic Acid N-Hydroxysuccinimide Ester (6-[(18)F]SFPy)
por: Basuli, Falguni, et al.
Publicado: (2020)

Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia
por: Sinclair, Paul B., et al.
Publicado: (2023)

Short Telomeres Result in Organismal Hypersensitivity to Ionizing Radiation in Mammals
por: Goytisolo, Fermín A., et al.
Publicado: (2000)

Loss of TG‐Interacting Factor 1 decreases survival in mouse models of myeloid leukaemia
por: Yan, Ling, et al.
Publicado: (2020)

BCL11A promotes myeloid leukemogenesis by repressing PU.1 target genes
por: Sunami, Yoshitaka, et al.
Publicado: (2022)

S150: TIMING AND CLONAL TRAJECTORY TO CHRONIC MYELOID LEUKAEMIA DRIVEN BY THE PHILADELPHIA CHROMOSOME
por: Kamizela, Aleksandra, et al.
Publicado: (2023)

Different loss of material in recurrent chromosome 20 interstitial deletions in Shwachman-Diamond syndrome and in myeloid neoplasms
por: Valli, Roberto, et al.
Publicado: (2013)

Chemotherapy of the Myeloid Leukaemias
por: Stuart, John
Publicado: (1980)

No equal opportunity for leukemia initiating cells
por: Verbiest, Tom, et al.
Publicado: (2018)

Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020)

Radiative capture on $^{242}$Pu for MOX fuel reactors
por: Guerrero, Carlos, et al.
Publicado: (2013)

Consensus on BCR‐ABL1 reporting in chronic myeloid leukaemia in the UK
por: Cross, Nicholas C. P., et al.
Publicado: (2018)

Preferential transcription of the mutated allele in NPM1 mutated acute myeloid leukaemia
por: Bailey, G. D., et al.
Publicado: (2020)

Pu /
por: Ramírez, Armando
Publicado: (2003)

Pu /
por: Ramírez,R. Armando
Publicado: (1977)

Erythropoiesis in Murine Myeloid Leukaemia
por: Tanaka, T.
Publicado: (1970)

Desacetylmethylcolchicine in the Treatment of Myeloid Leukaemia
por: Jelliffe, A. M., et al.
Publicado: (1956)

A Case of Myeloid Leukæmia
por: Ghosal, J. N.
Publicado: (1931)

Asciminib for chronic myeloid leukaemia
Publicado: (2022)

A Large Gene Network in Immature Erythroid Cells Is Controlled by the Myeloid and B Cell Transcriptional Regulator PU.1
por: Wontakal, Sandeep N., et al.
Publicado: (2011)

PU.1 and Haematopoietic Cell Fate: Dosage Matters
por: Mak, Ka Sin, et al.
Publicado: (2011)

Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (NPM1) Mutation
por: Chin, Lynn, et al.
Publicado: (2023)

Proceedings: Active immunotherapy in acute myeloid leukaemia.
por: Freeman, C. B., et al.
Publicado: (1975)

Rarity of microsatellite alterations in acute myeloid leukaemia.
por: Sill, H., et al.
Publicado: (1996)

Complex Variant of Philadelphia Translocation Involving Chromosomes 9, 12, and 22 in a Case with Chronic Myeloid Leukaemia
por: Malvestiti, F., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t6e8lsmv42bb7chusgvhf7eos4